Abstract
Type 2 diabetic osteoporosis (T2DOP) is a musculoskeletal system complication caused by type 2 diabetes (T2D), which is characterized by bone mass reduction, bone microstructure damage, bone strength reduction and increased fracture risk. T2DOP is asymptomatic in the early stage with complex pathogenesis and limited diagnostic method. Patients have high disability and mortality rates. At present, T2DOP is mainly treated with anti-diabetic and anti-osteoporosis medications. In this review, the characteristics, pathogenesis, diagnosis and treatment of T2DOP were summarized, and the future direction of T2DOP treatment was discussed to reduce the bone fracture risk.
| Translated title of the contribution | Research Progress on the Effect of Type 2 Diabetic Osteoporosis on Bone Fracture Risk |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 831-836 |
| Number of pages | 6 |
| Journal | Yiyong Shengwu Lixue/Journal of Medical Biomechanics |
| Volume | 38 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Research Progress on the Effect of Type 2 Diabetic Osteoporosis on Bone Fracture Risk'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver